TrialBMC medical genomics2012

Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer.

Ryan K Van LaarPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.